CTIS2023-504750-35-01
Recruiting
Phase 1
Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in the gastrointestinal tract, flatulence and bloating. - CGB_1109
CGBS GbR0 sites100 target enrollmentJuly 24, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Treatment of dyspeptic digestive complaints (cramps in the gastrointestinal tract, flatulence, bloating).
- Sponsor
- CGBS GbR
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients of either sex between the ages of \= 18 years and \< 60 years, Outpatients with persistent dyspeptic digestive symptoms over the past 3 months, Signed informed consent for participation and for collection and pseudonymized sharing of personal data, Negative pregnancy test for persons of childbearing potential at visit 1, Willingness to use a reliable method of contraception during participation in the clinical trial (Pearl index \< 1\): Complete abstinence, Sterilization (e.g., bilateral tubal ligation, ovariectomy, hysterectomy), Vasectomy of partner (if sole sexual partner), combined hormonal contraceptives (oral, intravaginal, dermal), progestogen\-containing hormonal contraceptives, copper IUD, hormone\-containing IUD, The 3 specific parameters (discomfort in the upper abdomen, feeling of pressure in the upper abdomen and feeling of fullness) must be classified as at least mild discomfort.
Exclusion Criteria
- •Uncooperative patients, Patients with diabetes mellitus, Patients in whom an organic cause for the dyspeptic complaints has been proven by diagnostics, Hypersensitivity to juniper oil, lactose monohydrate, cellulose powder, magnesium stearate (Ph. Eur.) or microcrystalline cellulose., Allergy to the humectant sorbitol (E420\), Patients with known galactose intolerance, lactase deficiency or glucose\-galactose malabsorption., Allergy to peanut or soy, Existing alcohol abuse or medication or drug abuse, Pregnant or breast\-feeding patients or those who plan to become pregnant during the clinical trial, Patients who are institutionalized by court order or by order of the authorities, Patients incapable of giving consent, Patients who do not have sufficient command of the German language (informed consent), Patients who are in a dependent relationship with the sponsor, investigator, other study personnel, or the study site, Patients with inflammatory kidney disease or severe kidney disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomized, placebo-controlled clinical trial on the efficacy of a mouthrinse containing 0.1% benzalkoniumchloride on the reduction of intraoral viral load and infectivity in SARS-CoV-2 positive subjects (COVID-19)U07.1COVID-19, virus identifiedDRKS00024454Poliklinik für Zahnerhaltung und ParodontologieUniversitätsklinikum Regensburg24
Not yet recruiting
Phase 1
Randomized, Placebo-Controlled Clinical Trial of Transdermal dihydrotestosterone Gel to Improve In Vitro Fertilization Outcomes In Women With Poor Ovarian ResponseACTRN12615001115527Prof.David Handelsman242
Completed
Not Applicable
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous LeishmaniasisPER-065-05DRUGS FOR NEGLECTED DISEASE INITIATIVE,
Completed
Phase 2
Efficacy of Gabapentin on flushing in menopausal womeIRCT201103011107N4Jundishapour Medical University60
Completed
Phase 2
The effect of hydroxyzine on bruxismBruxism.Other somatoform disordersIRCT201110203930N13Vice chancellor for research, Shiraz University of Medical Sciences30